These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19720087)

  • 1. Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1).
    Costa AC; Stasko MR; Schmidt C; Davisson MT
    Behav Brain Res; 2010 Jan; 206(1):52-62. PubMed ID: 19720087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field.
    Coussons-Read ME; Crnic LS
    Behav Genet; 1996 Jan; 26(1):7-13. PubMed ID: 8852727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.
    Belichenko NP; Belichenko PV; Kleschevnikov AM; Salehi A; Reeves RH; Mobley WC
    J Neurosci; 2009 May; 29(18):5938-48. PubMed ID: 19420260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome.
    Stasko MR; Costa AC
    Behav Brain Res; 2004 Sep; 154(1):1-17. PubMed ID: 15302106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test.
    Costa AC; Scott-McKean JJ; Stasko MR
    Neuropsychopharmacology; 2008 Jun; 33(7):1624-32. PubMed ID: 17700645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome.
    Martínez-Cué C; Rueda N; García E; Davisson MT; Schmidt C; Flórez J
    Behav Brain Res; 2005 Sep; 163(2):174-85. PubMed ID: 15941601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the rd1 mutation and host strain on hippocampal learning in mice.
    Clapcote SJ; Lazar NL; Bechard AR; Roder JC
    Behav Genet; 2005 Sep; 35(5):591-601. PubMed ID: 16184487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
    Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
    Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor dysfunction in a mouse model for Down syndrome.
    Costa AC; Walsh K; Davisson MT
    Physiol Behav; 1999 Dec 1-15; 68(1-2):211-20. PubMed ID: 10627083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn.
    Kida E; Rabe A; Walus M; Albertini G; Golabek AA
    Exp Neurol; 2013 Feb; 240():178-89. PubMed ID: 23201095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
    Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
    Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.
    Holtzman DM; Santucci D; Kilbridge J; Chua-Couzens J; Fontana DJ; Daniels SE; Johnson RM; Chen K; Sun Y; Carlson E; Alleva E; Epstein CJ; Mobley WC
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13333-8. PubMed ID: 8917591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice.
    Seo H; Isacson O
    Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.
    Kelley CM; Ash JA; Powers BE; Velazquez R; Alldred MJ; Ikonomovic MD; Ginsberg SD; Strupp BJ; Mufson EJ
    Curr Alzheimer Res; 2016; 13(1):84-96. PubMed ID: 26391045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mouse model of Down syndrome Ts65Dn presents visual deficits as assessed by pattern visual evoked potentials.
    Scott-McKean JJ; Chang B; Hurd RE; Nusinowitz S; Schmidt C; Davisson MT; Costa AC
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3300-8. PubMed ID: 20130276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities.
    Sago H; Carlson EJ; Smith DJ; Kilbridge J; Rubin EM; Mobley WC; Epstein CJ; Huang TT
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6256-61. PubMed ID: 9600952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.